EAM
TEVA icon

Eagle Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Eagle Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$665K Buy
38,857
+11,401
+42% +$200K ﹤0.01% 500
2024
Q2 		$449K Buy
27,456
+841
+3% +$13K ﹤0.01% 537
2024
Q1 		$370K Buy
+26,615
New +$335K ﹤0.01% 547
2021
Q4 		– Sell
-17,640
Closed -$171K – 622
2021
Q3 		$171K Buy
17,640
+1,713
+11% +$16K ﹤0.01% 579
2021
Q2 		$157K Buy
15,927
+937
+6% +$9.92K ﹤0.01% 585
2021
Q1 		$172K Buy
14,990
+9,087
+154% +$104K ﹤0.01% 583
2020
Q4 		$56K Sell
5,903
-10,319
-64% -$98.9K ﹤0.01% 539
2020
Q3 		$143K Sell
16,222
-466
-3% -$4.93K ﹤0.01% 559
2020
Q2 		$203K Buy
+16,688
New +$189K ﹤0.01% 550
2019
Q3 		– Sell
-18,421
Closed -$170K – 666
2019
Q2 		$170K Sell
18,421
-1,076
-6% -$13K ﹤0.01% 637
2019
Q1 		$305K Buy
19,497
+1,427
+8% +$25.2K ﹤0.01% 593
2018
Q4 		$278K Buy
18,070
+3,592
+25% +$73.6K ﹤0.01% 585
2018
Q3 		$342K Buy
+14,478
New +$336K ﹤0.01% 591
2016
Q4 		– Sell
-6,306
Closed -$290K – 662
2016
Q3 		$290K Sell
6,306
-255
-4% -$13.3K ﹤0.01% 607
2016
Q2 		$329K Buy
6,561
+740
+13% +$39.4K ﹤0.01% 605
2016
Q1 		$311K Buy
5,821
+1,133
+24% +$66.5K ﹤0.01% 601
2015
Q4 		$307K Buy
4,688
+727
+18% +$44.9K ﹤0.01% 613
2015
Q3 		$223K Buy
3,961
+186
+5% +$12.1K ﹤0.01% 632
2015
Q2 		$223K Buy
+3,775
New +$233K ﹤0.01% 634

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Eagle Asset Management's TEVA Position: Q3 2024 in Review

Eagle Asset Management increased its Teva Pharmaceuticals (TEVA) stake by 42% in Q3 2024, buying an estimated $200K and bringing the position to 38,857 shares worth $665K. The position accounts for ﹤0.01% of the portfolio, ranked #500.

Eagle Asset Management first reported a position in TEVA in Q2 2015 and has held it in 19 quarters since. 542 funds tracked by Wall St. Rank hold TEVA as of Q3 2024.

  • Eagle Asset Management held 38,857 shares of Teva Pharmaceuticals worth $665K as of Q3 2024.
  • Eagle Asset Management bought 11,401 Teva Pharmaceuticals shares in Q3 2024, an estimated $200K.
  • Teva Pharmaceuticals made up ﹤0.01% of Eagle Asset Management's portfolio in Q3 2024, its #500 holding.
  • Eagle Asset Management first reported a position in Teva Pharmaceuticals in Q2 2015 and has held it in 19 quarters since.
  • 542 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.